Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Learn More
Privileged Access to GI Immunology and Convergent Pathways
Changing the Paradigm for Biologics
Applied Molecular Transport Appoints Industry Veteran Shawn Cross as Chief Financial Officer and Promotes Bittoo Kanwar, M.D. to Chief Medical Officer | Learn More
No events scheduled at this time.